Literature DB >> 8132220

In vitro modulation of interleukin-1 beta secretion by cultured rat doxorubicin-stimulated whole glomeruli and dissociated mesangial glomerular cells.

T Bricio1, A Molina, A Martin, F Mampaso.   

Abstract

Doxorubicin-stimulated whole rat glomeruli and dissociated mesangial and resident glomerular macrophage cells produced the release of interleukin (IL)-1 beta cytokine. This activity increased after the addition of lipopolysaccharide (LPS) or LPS plus indomethacin to the cultures. In the presence of WEB2086 [platelet-activating factor (PAF)-acether antagonist], this activity showed a drastic reduction, without modification after sodium furegrelate (thromboxane synthetase inhibitor) was added to the cultures. Our results also demonstrate that this IL-1 beta activity is mainly produced by glomerular-resident macrophage cells. These findings support the important role by both IL-1 beta and PAF-acether mediator factors, at the cellular level, in the rat model of doxorubicin-induced nephrosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132220      PMCID: PMC1422285     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Role of oxygen radicals in adriamycin-induced nephrosis.

Authors:  S H Wu; Y C Yang; Z M Wang
Journal:  Chin Med J (Engl)       Date:  1990-04       Impact factor: 2.628

2.  The ultrastructure of the functioning kidney.

Authors:  L D Griffith; R E Bulger; B F Trump
Journal:  Lab Invest       Date:  1967-02       Impact factor: 5.662

3.  Characteristics of cell cultures derived from renal glomeruli.

Authors:  H Burlington; E P Cronkite
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Adriamycin nephrotoxicity.

Authors:  L F Fajardo; J R Eltringham; J R Stewart; M R Klauber
Journal:  Lab Invest       Date:  1980-09       Impact factor: 5.662

6.  Production of interleukin-1-like cytokine by cultured rat glomerular macrophages.

Authors:  F Mampaso; T Bricio; A Martin; A Molina
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

7.  Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys.

Authors:  E Pirotzky; J Bidault; C Burtin; M C Gubler; J Benveniste
Journal:  Kidney Int       Date:  1984-02       Impact factor: 10.612

8.  Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

Authors:  T Bertani; A Poggi; R Pozzoni; F Delaini; G Sacchi; Y Thoua; G Mecca; G Remuzzi; M B Donati
Journal:  Lab Invest       Date:  1982-01       Impact factor: 5.662

9.  IL-1-like production in adriamycin-induced nephrotic syndrome in the rat.

Authors:  T Bricio; A Molina; J Egido; E Gonzalez; F Mampaso
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin.

Authors:  L A Scharschmidt; M J Dunn
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  3 in total

1.  Migration inhibitory factor expression in experimentally induced endotoxemia.

Authors:  M Bacher; A Meinhardt; H Y Lan; W Mu; C N Metz; J A Chesney; T Calandra; D Gemsa; T Donnelly; R C Atkins; R Bucala
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

Review 2.  Use of anti-cancer drugs, mitocans, to enhance the immune responses against tumors.

Authors:  T Hahn; M J Polanczyk; A Borodovsky; L V Ramanathapuram; E T Akporiaye; S J Ralph
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

Review 3.  Platelet-activating factor and the cytokine network in inflammatory processes.

Authors:  B Bonavida; J M Mencia-Huerta
Journal:  Clin Rev Allergy       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.